Case study: Highly potent tech transfer and commercial manufacturing

Oct. 14, 2014
The manufacture of a Highly Potent Active Pharmaceutical Ingredient (HPAPI) compound can present many challenges due to the complex handling required for toxic substances.

The successful and safe manufacture of HPAPIs require the availability of a highly skilled team of staff with the right experience, the proper evaluation and training procedures being in place and the use of contained facilities.

This case study demonstrates how a commercial manufacturing partnership between a pharmaceutical contract manufacturer and a large pharmaceutical company resulted in the establishment of a high volume process for Highly Potent Active Pharmaceutical Ingredients.

Latest

Unraveling the Complexity of Tech Transfer

April 25, 2024
With the computing power available, we can speed up the process of collecting and disseminating data to save valuable time for life sciences manufacturers.

State of Smart Manufacturing Report

April 25, 2024
Download this free report for the latest research about how leading manufacturers are harnessing smart manufacturing technology and how you can too.

Digital Twins Help Polpharma Maintain Quality

April 25, 2024
Discover how Polpharma implemented a user-friendly, smart platform for employee training, maintenance and installation supervision.

Modernize OT Cybersecurity to Mitigate Risk

April 25, 2024
Rockwell Automation supports industry-leading Consumer Packaged Goods company, Church & Dwight, along their industrial cybersecurity journey.